GMAB logo

GMAB
Genmab - ADR

1,090
Mkt Cap
$16B
Volume
10,212.00
52W High
$35.43
52W Low
$19.59
PE Ratio
20.09
GMAB Fundamentals
Price
$26.66
Prev Close
$26.90
Open
$26.82
50D MA
$27.03
Beta
0.67
Avg. Volume
1.6M
EPS (Annual)
$1.55
P/B
2.91
Rev/Employee
$1.23M
$23,019.96
Loading...
Loading...
News
all
press releases
Genmab A/S Sponsored ADR (NASDAQ:GMAB) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
Shares of Genmab A/S Sponsored ADR (NASDAQ:GMAB - Get Free Report) have received an average recommendation of "Moderate Buy" from the twelve analysts that are covering the company, MarketBeat reports. Three research analysts have rated the stock with a hold rating, seven have given a buy rating and...
MarketBeat·11d ago
News Placeholder
More News
News Placeholder
What is HC Wainwright's Forecast for Genmab A/S Q2 Earnings?
Genmab A/S Sponsored ADR (NASDAQ:GMAB - Free Report) - Research analysts at HC Wainwright boosted their Q2 2026 earnings per share estimates for shares of Genmab A/S in a report released on Thursday, April 30th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings o...
MarketBeat·11d ago
News Placeholder
Oppenheimer Asset Management Inc. Acquires 48,894 Shares of Genmab A/S Sponsored ADR $GMAB
Oppenheimer Asset Management Inc. raised its holdings in shares of Genmab A/S Sponsored ADR (NASDAQ:GMAB - Free Report) by 15.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 364,756 shares of the company's stock after...
MarketBeat·13d ago
News Placeholder
Genmab A/S (OTCMKTS:GNMSF) Sees Strong Trading Volume - Still a Buy?
Genmab A/S (OTCMKTS:GNMSF) Sees Large Volume Increase - Should You Buy...
MarketBeat·15d ago
News Placeholder
HC Wainwright Has Lowered Expectations for Genmab A/S (NASDAQ:GMAB) Stock Price
HC Wainwright reduced their price target on Genmab A/S from $40.00 to $38.00 and set a "buy" rating for the company in a report on Thursday...
MarketBeat·15d ago
News Placeholder
Genmab A/S (GMAB) Projected to Post Earnings on Thursday
Genmab A/S (NASDAQ:GMAB) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at...
MarketBeat·15d ago
News Placeholder
Pictet Asset Management Holding SA Takes $33.84 Million Position in Genmab A/S Sponsored ADR $GMAB
Pictet Asset Management Holding SA bought a new position in shares of Genmab A/S Sponsored ADR (NASDAQ:GMAB - Free Report) during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 1,098,550 shares of the company's stock, valued at approximatel...
MarketBeat·15d ago
News Placeholder
Genmab A/S (GNMSF) Expected to Announce Quarterly Earnings on Thursday
Genmab A/S (OTCMKTS:GNMSF) will be releasing earnings on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-genmab-as-stock-1...
MarketBeat·15d ago
News Placeholder
Genmab A/S (OTCMKTS:GNMSF) Short Interest Up 25.8% in April
Genmab A/S (OTCMKTS:GNMSF - Get Free Report) was the target of a significant increase in short interest during the month of April. As of April 15th, there was short interest totaling 120,139 shares, an increase of 25.8% from the March 31st total of 95,479 shares. Based on an average daily volume...
MarketBeat·16d ago
News Placeholder
ABBV Beats on Q1 Earnings & Sales, Raises '26 EPS View
AbbVie tops Q1 estimates on strong Rinvoq and Skyrizi sales, lifts 2026 EPS outlook and gains premarket despite continued Humira and Imbruvica declines.
Zacks·16d ago
<
1
2
...
>

Latest GMAB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.